OXYGENTAPH.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
OXYGENTAPH.BOOxygenta Pharmaceutical Ltd.	$52.76	-1.27%	$2.0B	—
AMBALALSA.BOAmbalal Sarabhai Enterprises Limited	$39.36	+1.89%	$3.0B	—
BDH.BOBDH Industries Limited	$500.00	-1.01%	$2.9B	—
CORALAB.BOCoral Laboratories Limited	$570.90	+0.95%	$2.0B	—
KIMIABL.BOKimia Biosciences Ltd.	$28.81	+1.44%	$1.4B	—
NATCAPSUQ.BONatural Capsules Limited	$172.75	-4.72%	$1.8B	—
NURECA.BONureca Limited	$334.50	+2.61%	$3.3B	—

Source: Financial Modeling Prep · peers by sector/industry

Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.

www.oxygentapharma.com

Employees: 170
IPO / List date: Jan 3, 2000
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds OXYGENTAPH.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in OXYGENTAPH.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded OXYGENTAPH.BO yet.